Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (11): 1011-1014.DOI: 10.3969/j.issn.1673-8640.2019.11.012
• Orginal Article • Previous Articles Next Articles
Received:2019-03-04
Online:2019-11-30
Published:2019-12-05
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.11.012
| 组别 | 例数 | 初产妇 [例（%）] | 血红蛋白 （g/L） | 宫颈长度（cm） | BMI （kg/m2） | 剖宫产史 [例（%）] |
|---|---|---|---|---|---|---|
| 早产组A | 52 | 30（57.7） | 116.15±14.66 | 3.48±0.44 | 20.57±1.87 | 8（15.4） |
| 对照组A | 52 | 31（59.6） | 122.04±10.63 | 3.67±0.53 | 21.45±2.14 | 2（3.8） |
| 统计值 | 0.040 | 2.219 | 1.835 | 2.150 | 2.766 | |
| P值 | 0.842 | 0.021 | 0.048 | 0.032 | 0.124 | |
| 组别 | 流产史 [例（%）] | 妊娠糖尿病 [例（%）] | 妊娠高血压 [例（%）] | 宫缩 [例（%）] | 胎膜早破 [例（%）] | 下生殖道、泌尿道感染 [例（%）] |
| 早产组A | 19（36.5） | 10（19.2） | 2（3.8） | 44（84.6） | 29（55.8） | 13（25） |
| 对照组A | 14（26.9） | 1（1.9） | 0（0） | 43（82.7） | 3（5.8） | 9（17.3） |
| 统计值 | 1.110 | 6.506 | 2.812 | 0.070 | 28.212 | 0.922 |
| P值 | 0.292 | 0.011 | 0.495 | 0.791 | 0.000 | 0.337 |
| 组别 | 例数 | 初产妇 [例（%）] | 血红蛋白 （g/L） | 宫颈长度（cm） | BMI （kg/m2） | 剖宫产史 [例（%）] |
|---|---|---|---|---|---|---|
| 早产组A | 52 | 30（57.7） | 116.15±14.66 | 3.48±0.44 | 20.57±1.87 | 8（15.4） |
| 对照组A | 52 | 31（59.6） | 122.04±10.63 | 3.67±0.53 | 21.45±2.14 | 2（3.8） |
| 统计值 | 0.040 | 2.219 | 1.835 | 2.150 | 2.766 | |
| P值 | 0.842 | 0.021 | 0.048 | 0.032 | 0.124 | |
| 组别 | 流产史 [例（%）] | 妊娠糖尿病 [例（%）] | 妊娠高血压 [例（%）] | 宫缩 [例（%）] | 胎膜早破 [例（%）] | 下生殖道、泌尿道感染 [例（%）] |
| 早产组A | 19（36.5） | 10（19.2） | 2（3.8） | 44（84.6） | 29（55.8） | 13（25） |
| 对照组A | 14（26.9） | 1（1.9） | 0（0） | 43（82.7） | 3（5.8） | 9（17.3） |
| 统计值 | 1.110 | 6.506 | 2.812 | 0.070 | 28.212 | 0.922 |
| P值 | 0.292 | 0.011 | 0.495 | 0.791 | 0.000 | 0.337 |
| 组别 | 例数 | IL-6（pg/mL） | PAF（ng/mL） | fFN（ng/mL） | CRH（ng/mL） |
|---|---|---|---|---|---|
| 早产组B | |||||
| 孕12周 | 24 | 10.61（4.98~26.15） | 1.90（1.19~4.77） | 4.88（4.21~5.72） | 1.54（0.22~2.67） |
| 孕32周 | 24 | 4.58（1.63~9.20） | 1.69（0.00~6.99） | 41.41（41.19~41.79） | 0.38（0.23~0.50） |
| 对照组B | |||||
| 孕12周 | 28 | 10.29（5.01~25.61） | 1.24（0.66~1.28） | 4.73（4.01~8.35） | 1.49（0.58~3.30） |
| 孕32周 | 28 | 9.23（6.75~73.33） | 1.86（1.86~2.66） | 43.11（41.35~44.09） | 0.25（0.15~0.34） |
| 组别 | 例数 | IL-6（pg/mL） | PAF（ng/mL） | fFN（ng/mL） | CRH（ng/mL） |
|---|---|---|---|---|---|
| 早产组B | |||||
| 孕12周 | 24 | 10.61（4.98~26.15） | 1.90（1.19~4.77） | 4.88（4.21~5.72） | 1.54（0.22~2.67） |
| 孕32周 | 24 | 4.58（1.63~9.20） | 1.69（0.00~6.99） | 41.41（41.19~41.79） | 0.38（0.23~0.50） |
| 对照组B | |||||
| 孕12周 | 28 | 10.29（5.01~25.61） | 1.24（0.66~1.28） | 4.73（4.01~8.35） | 1.49（0.58~3.30） |
| 孕32周 | 28 | 9.23（6.75~73.33） | 1.86（1.86~2.66） | 43.11（41.35~44.09） | 0.25（0.15~0.34） |
| [1] | 杨孜,郭艳军. 早期早产的研究进展[J]. 实用妇产科杂志,2005,21(11):652-654. |
| [2] | BLENCOWE H,COUSENS S,CHOU D,et al.Born too soon:the global epidemiology of 15 million preterm births[J]. Reprod Health,2013,10(Suppl 1):S2. |
| [3] | 孙丽洲,刘丽萍. 自发性早产的高危因素筛查及评价[J]. 实用妇产科杂志,2012,28(10):803-805. |
| [4] | POLETTINI J,COBO T,KACEROVSKY M,et al.Biomarkers of spontaneous preterm birth:a systematic review of studies using multiplex analysis[J]. J Perinat Med,2017,45(1):71-84. |
| [5] | 边旭明,付晨薇. 早产的定义分类和诊断[J]. 现代妇产科进展,2011,20(3):164-165. |
| [6] | FREY H A,KLEBANOFF M A.The epidemiology,etiology,and costs of preterm birth[J]. Semin Fetal Neonatal Med,2016,21(2):68-73. |
| [7] | RUBENS C E,SADOVSKY Y,MUGLIA L,et al. Prevention of preterm birth:harnessing science to address the global epidemic[J]. Sci Transl Med,2014,6(262):262sr5. |
| [8] | YUAN M,JORDAN F,MCLNNES I B,et al.Leukocytes are primed in peripheral blood for activation during term and preterm labour[J]. Mol Hum Reprod,2009,15(11):713-724. |
| [9] | SHAHSHAHAN Z,HASHEMI L.Maternal serum cytokines in the prediction of preterm labor and response to tocolytic therapy in preterm labor women[J]. Adv Biomed Res,2014,3:126. |
| [10] | ISIK Y,CELIK H,AVCI B,et al.Maternal serum interlukin-6 level in preterm labor[J]. Ginekol Pol,2013,84(5):368-372. |
| [11] | YAVARI KIA P,BARADARAN B,SHAHNAZI M,et al.Maternal serum and cervicovaginal IL-6 in patients with symptoms of preterm labor[J]. Iran J Immunol,2016,13(3):229-236. |
| [12] | NEGRÃO-CORRÊA D,SOUZA D G,PINHO V,et al. Platelet-activating factor receptor deficiency delays elimination of adult worms but reduces fecundity in strongyloides venezuelensis-infected mice[J]. Infect Immun,2004,72(2):1135-1142. |
| [13] | AGRAWAL V,JAISWAL M K,ILIEVSKI V,et al.Platelet-activating factor:a role in preterm delivery and an essential interaction with Toll-like receptor signaling in mice[J]. Biol Reprod,2014,91(5):119. |
| [14] | 丁依玲,黄丽霞. 血小板激活因子及其受体在早产中的表达及意义[J]. 中国实用妇科与产科杂志,2007,23(1):50-52. |
| [15] | GRAZIANI G,FERRANDINA G,POZZOLI G.Corticotropin-releasing hormone receptor-1 in human endometrial cancer[J]. Oncol Rep,2006,15(2):375-379. |
| [16] | JONES SA,LAO T,HANNAH M E,et al.Corticotrophin-releasing hormone and preterm labor[J]. J Soc Gynecol Invest,1995,2(2):286. |
| [17] | IAMS J D.Prediction and early detection of preterm labor[J].Obstet Gynecol,2003,101(2):402-412. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
